Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbhfiledCriticalBoehringer Ingelheim International Gmbh
Publication of ECSP067003ApublicationCriticalpatent/ECSP067003A/en
La presente invención se refiere a formulaciones en polvo para la inhalación que contienen compuestos enantioméricamente puros de la fórmula general (1) (1)en la que los radicales R1, R2, R3 y R4 pueden tener los significados mencionados en las reivindicaciones y en la descripción, eventualmente en forma de sus sales por adición de ácidos farmacéuticamente tolerables, así como eventualmente en combinación con un coadyuvante farmacéuticamente tolerable, a procedimientos para su preparación y a su uso como medicamentos, en especial como medicamentos para el tratamiento de enfermedades de las vías respiratorias.The present invention relates to powder formulations for inhalation containing enantiomerically pure compounds of the general formula (1) (1) in which the radicals R1, R2, R3 and R4 can have the meanings mentioned in the claims and in the description, possibly in the form of their salts by the addition of pharmaceutically tolerable acids, as well as, in combination with a pharmaceutically tolerable adjuvant, to procedures for their preparation and use as medicaments, especially as medicaments for the treatment of respiratory tract diseases .
ECSP0670032004-05-142006-11-13
POWDER FORMULATIONS FOR INHALATION, WHICH CONTAIN BETA-ENANTIOMERICALLY PURE AGONISTS
ECSP067003A
(en)
SUBSTITUTED DERIVATIVES OF THE ACETATE OF 8- (4-METOXIFENIL) -2,3,4,8-TETRAHYDROIMIDAZO- [1,5-A] -PIRIMIDIN-6-AMINA, PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS
DERIVED FROM THE 1, 3, 5-TRIAZINA-2, 4-DIAMINAS-6-SUBSTITUTED-N-SUBSTITUTED AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS AND APPLICATIONS.
SUBSTITUTED DERIVATIVES OF N4- (5-METHYL-1H-PIRAZOL-3-IL) - 1,3,5-TRIAZINA-2,4-DIAMINE, THEIR ENANTIOMERS, PHARMACEUTICALLY ACCEPTABLE SALTS OF THE SAME, COMPOSITIONS, PREPARATION PROCESSES AND APPLICATIONS
DERIVATIVES OF 2, 6-QUINOLINILO, A PHARMACEUTICAL PREPARATION THAT CONTAINS THEM AND ITS EMPLOYMENT IN THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF DEPENDENT DISEASES OF INTEGRINES ALFA4BETA1 AND / OR ALFA4BETA7
SUBSTITUTED DERIVATIVES OF N- (5- (2-PROPILAMINE.1.HYDROXYETHYL) -2-HDROXIFENIL) METHANE SULFONAMIDE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND APPLICATIONS.